Persian Bioelectromagnetics (Pars Tarava) has been operating since 2018 as the first and only producer of electroporation and electrochemotherapy devices in Iran. Our initial focus was to establish a bridge between medical universities and industry. Recently, our group has created innovative products aimed at enhancing research and treatment, instilling greater hope. Persian Bioelectromagnetics initiated its foundational research in 2006, and our team members have participated in various projects focused on electroporation and electrochemotherapy.
This company exclusively focuses on electroporation and electrochemotherapy, which enables us to share our experience and expertise with you, providing a wide range of creative tools to advance research and treatment. In alignment with other companies that manufacture non-ionization systems, we provide the most advanced techniques available to hospital and university users. The therapeutic advancements achieved by the company’s colleagues have enabled the treatment of superficial, deep, and brain cancers. The Persian bioelectromagnetics company sells electroporation devices that can use up to 3,000 volts and handle very high currents, along with 2 mm and 4 mm electroporation cuvettes.
Pars Tarava’s enduring achievements include the development of homegrown technologies for cancer treatment, the creation of advanced laboratory products, and the continuous enhancement of these innovations based on up-to-date global research.
Today, the Production and Technology Division of Pars Bioelectromagnetics is responsible for transforming these scientific advances into market-ready solutions. At Pars Tarava, we envision expanding the frontiers of bioelectromagnetic science and introducing groundbreaking methods to treat various forms of cancer, whether superficial or deep-seated, in both humans and animals. This vision is realized through a smart integration of research, manufacturing, with the ultimate goal of contributing meaningfully to Iran and the whole world’s scientific and medical community.
